CNTB
Connect Biopharma Holdings
CNTB
CNTB
29 hedge funds and large institutions have $87.4M invested in Connect Biopharma Holdings in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
81% less capital invested
Capital invested by funds: $467M → $87.4M (-$380M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $88K
Holders
29
Holding in Top 10
–
Calls
–
Puts
$88K
Top Buyers
| 1 | +$13.9M | |
| 2 | +$3.09M | |
| 3 | +$2.91M | |
| 4 |
ACM
Altium Capital Management
New York
|
+$1.95M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.37M |
Top Sellers
| 1 | -$50.4M | |
| 2 | -$27.4M | |
| 3 | -$15.6M | |
| 4 |
BlackRock
New York
|
-$3.4M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.33M |